ROSSARINSERossari Biotech LimitedMediumNeutral
Announced Fri, 29 Aug · 15:26 IST

Yash Sunil Chari has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Creeping Acquisition Near ThresholdPromoter Stake BuyOwnership Changes View source PDF

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Yash Sunil Chari has submitted a disclosure to the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing reports an acquisition that was made by relying on the exemption provided under Regulation 10 of the SAST rules, meaning the transaction did not trigger the standard open offer requirement to other shareholders. The specific details of the acquisition (size, price, and resulting shareholding) are not included in this filing snippet. Regulation 10 exemptions typically apply to inter se promoter transfers, creeping acquisitions within prescribed limits, or transactions pursuant to approved schemes.

Likely market impact

For retail shareholders, this is largely a procedural compliance filing and not directly price-actionable. However, the nature of the acquisition (whether it signals promoter consolidation, a creeping buy toward a threshold, or an inter se transfer) would matter — investors should check the BSE/NSE filing for actual share numbers and percentage changes to assess any meaningful change in promoter-group ownership.